These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 22323339)

  • 41. Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus.
    Gambelunghe G; Gerli R; Bocci EB; Del Sindaco P; Ghaderi M; Sanjeevi CB; Bistoni O; Bini V; Falorni A
    Rheumatology (Oxford); 2005 Mar; 44(3):287-92. PubMed ID: 15522921
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of mannose binding lectin (MBL) gene polymorphism and serum MBL concentration with characteristics and progression of systemic lupus erythematosus.
    Takahashi R; Tsutsumi A; Ohtani K; Muraki Y; Goto D; Matsumoto I; Wakamiya N; Sumida T
    Ann Rheum Dis; 2005 Feb; 64(2):311-4. PubMed ID: 15647440
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
    Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
    Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users.
    Tu HF; Wu CH; Kao SY; Liu CJ; Liu TY; Lui MT
    J Oral Pathol Med; 2007 Aug; 36(7):409-14. PubMed ID: 17617834
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Matrix metalloproteinase (MMP)-2 genetic variants modify the circulating MMP-2 levels in end-stage kidney disease.
    Marson BP; Lacchini R; Belo V; Dickel S; da Costa BP; Poli de Figueiredo CE; Tanus-Santos JE
    Am J Nephrol; 2012; 35(3):209-15. PubMed ID: 22302011
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus.
    Lee AB; Godfrey T; Rowley KG; Karschimkus CS; Dragicevic G; Romas E; Clemens L; Wilson AM; Nikpour M; Prior DL; Best JD; Jenkins AJ
    Intern Med J; 2006 Apr; 36(4):237-43. PubMed ID: 16640741
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement.
    Trysberg E; Blennow K; Zachrisson O; Tarkowski A
    Arthritis Res Ther; 2004; 6(6):R551-6. PubMed ID: 15535833
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of MMP-2 and its inhibitor TIMP-2 as biomarkers for susceptibility to systemic lupus erythematosus.
    Vira HJ; Pradhan VD; Umare VD; Chaudhary AK; Rajadhyksha AG; Nadkar MY; Ghosh K; Nadkarni AH
    Biomark Med; 2020 Aug; 14(12):1109-1119. PubMed ID: 32969251
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of MMP-1 promoter polymorphisms on GCF MMP-1 levels and outcome of periodontal therapy in patients with severe chronic periodontitis.
    Pirhan D; Atilla G; Emingil G; Sorsa T; Tervahartiala T; Berdeli A
    J Clin Periodontol; 2008 Oct; 35(10):862-70. PubMed ID: 18710412
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A functional polymorphism in fas (CD95/APO-1) gene promoter associated with systemic lupus erythematosus.
    Kanemitsu S; Ihara K; Saifddin A; Otsuka T; Takeuchi T; Nagayama J; Kuwano M; Hara T
    J Rheumatol; 2002 Jun; 29(6):1183-8. PubMed ID: 12064832
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Polymorphism of Fc gamma RIIIA-158F/V gene and promoter region of IL-10 gene in systemic lupus erythematosus in Kazakhs].
    Guseva IA; Omarbekova ZhE; Miakotkin VA
    Ter Arkh; 2003; 75(5):36-41. PubMed ID: 12847896
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The complex nature of the interaction between disease activity and therapy on the lipid profile in patients with pediatric systemic lupus erythematosus.
    Sarkissian T; Beyenne J; Feldman B; Adeli K; Silverman E
    Arthritis Rheum; 2006 Apr; 54(4):1283-90. PubMed ID: 16575849
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor necrosis factor alpha promoter polymorphism -308 G/A in Brazilian patients with systemic lupus erythematosus.
    Angelo HD; da Silva HA; Asano NM; Muniz MT; de Mascena Diniz Maia M; de Souza PR
    Hum Immunol; 2012 Nov; 73(11):1166-70. PubMed ID: 22884981
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elevated levels of serum soluble Fas are associated with organ and tissue damage in systemic lupus erythematosus among Chinese.
    Hao JH; Ye DQ; Zhang GQ; Liu HH; Dai H; Huang F; Pan FM; Su H; Dong MX; Chen H; Wang Q; Zhang XJ
    Arch Dermatol Res; 2006 Jan; 297(7):329-32. PubMed ID: 16328345
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lack of association between the polymorphism at the heat-shock protein (HSP70-2) gene and systemic lupus erythematosus (SLE) in the Mexican mestizo population.
    Vargas-Alarcón G; Granados J; Martínez-Laso J; Gómez-Casado E; Zuñiga J; Salgado N; Hernández-Pacheco G; Hesiquio R; Rodríguez-Reyna TS; Gamboa R; Alcocer-Varela J; Arnaiz-Villena A
    Genes Immun; 2000 Aug; 1(6):367-70. PubMed ID: 11196683
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of apolipoprotein E gene polymorphism with ischemic stroke involving large-vessel disease and its relation to serum lipid levels.
    Saidi S; Slamia LB; Ammou SB; Mahjoub T; Almawi WY
    J Stroke Cerebrovasc Dis; 2007; 16(4):160-6. PubMed ID: 17689412
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus.
    Peros E; Geroldi D; Bugatti S; Caporali R; Rossi P; Montecucco C; D'Angelo A; Emanuele E
    Int J Mol Med; 2005 Apr; 15(4):661-5. PubMed ID: 15754029
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vitamin D status in systemic lupus erythematosus patients and its association with selected clinical and laboratory parameters.
    Bogaczewicz J; Sysa-Jedrzejowska A; Arkuszewska C; Zabek J; Kontny E; McCauliffe D; Wozniacka A
    Lupus; 2012 Apr; 21(5):477-84. PubMed ID: 22065093
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Angiotensin-converting enzyme (insertion/deletion) and endothelial nitric oxide synthase polymorphisms in patients with systemic lupus erythematosus.
    Douglas G; Reilly C; Dooley MA; Page G; Cooper G; Gilkeson G
    J Rheumatol; 2004 Sep; 31(9):1756-62. PubMed ID: 15338496
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of Matrix Metalloproteinase-2 (MMP-2) and MMP-9 Promoter Polymorphisms, Their Serum Levels, and Activities with Coronary Artery Calcification (CAC) in an Iranian Population.
    Elahirad S; Elieh Ali Komi D; Kiani A; Mohammadi-Noori E; Vaisi-Raygani A; Mozafari H; Bahrehmand F; Saidi M; Toupchi-Khosroshahi V; Salehi N
    Cardiovasc Toxicol; 2022 Feb; 22(2):118-129. PubMed ID: 34731407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.